Tennessee lawmakers are weighing whether to fund clinical trials of ibogaine, a psychedelic compound advocates say could help veterans and others with PTSD and addiction.
The Helping Open Pathways to Effective (HOPE) Treatment Act was introduced in January and remains under consideration in both Senate and House committees. Advocates rallied for action on the proposal at the state Capitol Feb. 24.
Ibogaine, pronounced i-bow-gain, is illegal for use ...
Treatment-resistant depression (TRD) is currently considered one of the most significant challenges in psychiatry: Millions of patients do not respond adequately to existing medications, alongside heavy costs for healthcare systems and ongoing functional loss.
Against this backdrop, the Israeli biopharma company PsyRx is developing an innovative combination drug that seeks to address one of the main failure points of antidepressant treatments – the long time until a significant clinical effect ...
Studies have explored the connection between pets and mental health.
In 2024, a group of researchers published a paper ...
Ibogaine is a plant-based treatment derived from the African iboga tree. The budget allocates funding for state programs and operations for the …
Ibogaine is a powerful psychedelic derived from the iboga shrub native to Gabon, Central Africa. It should only be taken under the supervision of …